You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.
We guide you every step of the way, combining our deep clinical expertise in blood cancers and nonmalignant blood diseases (also called benign hematology) with a commitment to meet your unique needs.
Request an appointment
Why choose SCCA for blood disorder treatment?
Experts in blood disorders
SCCA patients receive state-of-the-art care from some of the world’s leading doctors. Many blood disorders are rare, and treating them can be difficult. Our hematologists and hematologist-oncologists have the expertise to diagnose and treat even the most complex or uncommon conditions. They are part of the UW Medicine Hematology team.
Comprehensive blood disorder treatment
Along with treating all types of blood-related cancer, like leukemia and lymphoma, our specialists care for many patients with nonmalignant blood diseases, such as aplastic anemia, inherited bone marrow failure syndromes, sickle cell disease and many others.
Blood disorder clinical trials
To give you access to the most innovative treatments, SCCA unites the leading researchers and cancer specialists of Fred Hutchinson Cancer Research Center and UW Medicine so you can take part in clinical trials for your disease that are not available everywhere.
Bone marrow transplant for blood disorders
The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We pioneered bone marrow transplants and have performed more than any other institution in the world. For some blood disorders — including some nonmalignant diseases — a transplant provides the best hope for a cure.
A national leader in cancer care
SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report. We are one of the few cancer centers in the country with a Hematologic Malignancy Genetics Clinic.
NCI comprehensive cancer center
We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer. Our doctors and scientists bring the same commitment to nonmalignant blood disorders.